| Literature DB >> 36137133 |
Lauri Jouhi1, Jenna Sikiö2, Anni Suomalainen3, Rayan Mroueh1, Antti Mäkitie1,4,5, Jukka H Meurman2.
Abstract
BACKGROUND: Human papilloma virus is associated with oral and oropharyngeal cancer. Our aim was to examine oral health in patients with oropharyngeal (OPSCC) and oral tongue cancer (OTSCC), expecting better oral health among OPSCC patients.Entities:
Mesh:
Year: 2022 PMID: 36137133 PMCID: PMC9499192 DOI: 10.1371/journal.pone.0274813
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Baseline clinic-pathological characteristics of the patients with oropharyngeal (OPSCC) or oral tongue (OTSCC) squamous cell carcinoma.
| Total | OPSCC | OTSCC |
| |
|---|---|---|---|---|
| No of patients (%) | 114 (100) | 55 (48.2) | 59 (51.8) | |
| Age yrs. (range) | 59.5 (30.4–89.6) | 59.5 (33.3–89.6) | 59.5 (30.4–85.7) | 0.980 |
| Gender | 0.174 | |||
| Male | 78 (68.4) | 41 (74.5) | 37 (62.7) | |
| Female | 36 (31.6) | 14 (25.5) | 23 (37.3) | |
| Edentulous | 12 (10.5) | 5 (9.1) | 7 (11.9) | 0.630 |
| Smoking | 0.285 | |||
| Yes | 56 (58.3) | 30 (63.8) | 26 (53.1) | |
| No | 40 (41.7) | 17 (36.2) | 23 (46.9) | |
| Missing | 18 | 8 | 10 | |
| Heavy alcohol consumption | 0.432 | |||
| Yes | 29 (36.7) | 13 (32.5) | 16 (41.0) | |
| No | 50 (63.3) | 27 (67.5) | 23 (59.0) | |
| Missing | 35 | 15 | 20 | |
| TNM stage | <0.001 | |||
| I | 21 (18.8) | 4 (7.4) | 17 (29.3) | |
| II | 32 (28.6) | 7 (13.0) | 25 (43.1) | |
| III | 11 (9.8) | 6 (11.1) | 5 (8.6) | |
| IV | 48 (42.9) | 37 (68.5) | 11 (19.0) | |
| Missing | 2 | 1 | 1 | |
| Grade | 0.002 | |||
| 1 | 23 (26.7) | 8 (14.8) | 15 (46.9) | |
| 2 | 30 (34.9) | 19 (35.2) | 11 (34.4) | |
| 3 | 33 (38.4) | 27 (50.0) | 6 (18.8) | |
| Missing | 28 | 1 | 27 | |
| HPV status | ||||
| Positive | 21 (46.7) | |||
| Negative | 24 (53.3) | |||
| Missing | 10 | |||
| Median number of drugs in use (range) | 1 (0–9) | 1 (0–9) | 2 (0–9) | 0.411 |
| Mucosal lesion | 11 (9.6) | 2 (3.6) | 9 (15.3) | 0.036 |
| C00-D48 | 11 (9.6) | 2 (3.6) | 9 (15.3) | 0.036 |
| K00-K14 | 9 (7.9) | 1 (1.8) | 8 (13.6) | 0.033 |
Dental indexes of the study population with oropharyngeal (OPSCC) and oral tongue (OTSCC) squamous cell carcinoma.
| Total | OPSCC | OTSCC |
| |||
|---|---|---|---|---|---|---|
| Total | HPV+ | HPV- | ||||
| No of patients (%) | 114 (100) | 55 (48.2) | 21 (46.7) | 24 (53.3) | 59 (51.8) | |
| Caries | 0.129 | |||||
| 0 | 36 (31.6) | 12 (21.8) | 7 (33.3) | 4 (16.7) | 24 (40.7) | 0.079 |
| 1 | 40 (35.1) | 22 (40.0) | 9 (42.9) | 11 (45.8) | 18 (30.5) | 0.703 |
| 2 | 22 (19.3) | 13 (23.6) | 5 (23.8) | 4 (16.7) | 9 (15.3) | 0.136 |
| 3 | 16 (14.0) | 8 (14.5) | 0 (0.0) | 5 (20.8) | 8 (13.6) | |
| Periodontitis | 0.608 | |||||
| 0 | 35 (30.7) | 16 (29.1) | 6 (28.6) | 7 (29.2) | 19 (32.2) | 0.738 |
| 1 | 37 (32.5) | 17(30.9) | 8 (38.1) | 8 (33.3) | 20 (33.9) | 1.000 |
| 2 | 36 (31.6) | 19 (34.5) | 7 (33.3) | 7 (29.2) | 17 (28.8) | 0.695 |
| 3 | 6 (5.3) | 3 (5.5) | 0 (0.0) | 2 (8.3) | 3 (5.1) | |
| Periapical lesions | 0.123 | |||||
| 0 | 36 (31.6) | 13 (23.6) | 2 (9.5) | 8 (33.3) | 23 (39.0) |
|
| 1 | 63 (55.3) | 33 (60.0) | 14 (66.7) | 14 (58.3) | 30 (50.8) |
|
| 2 | 8 (7.0) | 5 (9.1) | 2 (9.5) | 2 (8.3) | 3 (5.1) | 1.000 |
| 3 | 7 (6.1) | 4 (7.3) | 3 (14.3) | 0 (0.0) | 3 (5.1) | |
| Pericoronitis | 0.482 | |||||
| 0 | 113 (99.1) | 54 (98.2) | 21 (100.0) | 23 (95.8) | 59 (100.0) | 1.000 |
| 1 | 1 (0.9) | 1 (1.8) | 0 (0.0) | 1 (4.2) | 0 (0.0) | 0.289 |
| Residual roots |
| |||||
| 0 | 98 (86.0) | 42 (76.4) | 17 (81.0) | 19 (79.2) | 56 (94.9) | 0.720 |
| 1 | 7 (6.1) | 5 (9.1) | 2 (9.5) | 2 (8.3) | 2 (3.4) | 0.107 |
| 2 | 5 (4.4) | 5 (9.1) | 2 (9.5) | 1 (4.2) | 0 (0.0) |
|
| ≥3 | 4 (3.5) | 3 (5.5) | 0 (0.0) | 2 (8.3) | 1 (1.7) | |
| Furcation lesions | 0.412 | |||||
| 0 | 81 (71.1) | 35 (63.6) | 12 (57.1) | 17 (70.8) | 46 (78.0) | 0.388 |
| 1 | 14 (12.3) | 10 (18.2) | 4 (19.0) | 4 (16.7) | 4 (6.8) | 0.281 |
| 2 | 6 (5.3) | 4 (7.3) | 2 (9.5) | 1 (4.2) | 2 (3.4) | 1.000 |
| ≥3 | 13 (11.4) | 6 (10.9) | 3 (14.3) | 2 (8.3) | 7 (11.9) | |
| Vertical bone pockets | 0.916 | |||||
| 0.506 | ||||||
| 0 | 53 (46.5) | 21 (38.2) | 7 (33.3) | 10 (41.7) | 32 (54.2) | 0.692 |
| 1 | 24 (21.1) | 17 (30.9) | 6 (28.6) | 8 (33.3) | 7 (11.9) | 0.849 |
| 2 | 10 (8.8) | 7 (12.7) | 4 (19.0) | 2 (8.3) | 3 (5.1) | |
| ≥3 | 27 (23.7) | 10 (18.2) | 4 (19.0) | 4 (16.7) | 17 (28.8) | |
| Endodontic treatments | 0.260 | |||||
| 0.310 | ||||||
| 0 | 45 (39.5) | 20 (36.4) | 4 (19.0) | 9 (37.5) | 25 (42.4) | 0.054 |
| 1–2 | 33 (28.9) | 15 (27.3) | 8 (38.1) | 6 (25.0) | 18 (30.5) | 0.534 |
| 3–4 | 25 (21.9) | 13 (23.6) | 5 (23.8) | 7 (29.2) | 12 (20.3) | |
| ≥5 | 11 (9.6) | 7 (12.7) | 4 (19.0) | 2 (8.3) | 4 (6.8) | |
| Removable prostheses |
| |||||
| 0.142 | ||||||
| No | 88 (77.2) | 38 (69.1) | 18 (85.7) | 16 (66.7) | 50 (84.7) | 1.000 |
| Yes | 26 (22.8) | 17 (30.9) | 3 (14.3) | 8 (33.3) | 9 (15.3) | 0.078 |
| TDI score |
| |||||
| 0–2 | 40 (35.1) | 12 (21.8) | 8 (38.1) | 4 (16.7) | 28 (47.5) | 0.173 |
| 3–5 | 65 (57.0) | 38 (69.1) | 12 (57.1) | 18 (75.0) | 27 (45.8) | 0.678 |
| 6–8 | 9 (7.9) | 5 (9.1) | 1 (4.8) | 2 (8.3) | 4 (6.8) |
|
a OPSCC vs. OTSCC
b HPV+ OPSCC vs. HPV- OPSCC
c HPV+ OPSCC vs. OTSCC
d HPV- OPSCC vs. OTSCC